HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Vaccine Research & Development

WHO starts initiative for Vaccine Research that facilitates research and development (R&D) against microorganisms with significant economic burden and disease, with a particular focus on low and middle income countries. Our activities span the following areas:

  • Facilitation of early stage R&D in disease areas with no available vaccines or sub-optimal vaccines
  • Research to optimize public health impact where existing vaccines are underutilized,
  • Research to aid introduction decision-making and post-licensure assessments of risk/benefit
  • Research to improve monitoring and evaluation of vaccines in use in immunization.    

In the past days, the process of vaccine development occur through a series of steps that  take a long period of time or many years. Now, in given the urgent need for COVID-19 vaccines, uncommon financial investments and scientific collaborations are changing how vaccines are developed.

Committee Members
Speaker at International Vaccines Congress 2023 - Stefan Gluck

Stefan Gluck

Jessica McDonough PhD Co-Founder Attivare, United States
Speaker at International Vaccines Congress 2023 - Hemanta Kumar Kar

Hemanta Kumar Kar

Kalinga Institute of Medical Sciences(KIMS), India
Speaker at International Vaccines Congress 2023 - Sudhakar Bangera

Sudhakar Bangera

MBBS, MD, MMedSc, Fellow-Vaccinology Managing Partner AILEEN Clinical Research Services AILEEN, India
Speaker at International Vaccines Congress 2023 - Mayra Ramos Suzarte

Mayra Ramos Suzarte

Center of Molecular Immunology, Cuba

Submit your abstract Today